Impact of Anti-obesity Drugs on Gastric Motility and Implications for the Management of Dyspepsia
From BSG From Top to Bottom · 00:09:48
Show by British Society of Gastroenterology
In this episode, Dr. Asma Fikree, Consultant Neurogastroenterologist at UCLH and Chair of the BSG Neurogastroenterology & Motility Section and Dr Maria Eugenicos, Senior Lecturer/Neurogastroenterologist, Western General Hospital, Edinburgh discuss the effects of anti-obesity medications on gastric motility, dyspepsia, and gastroparesis-like symptoms. The discussion covers the management of nausea, vomiting and delayed gastric emptying, considerations before endoscopy and surgery, the phenomenon of tachyphylaxis, and practical approaches to dose titration. Dr. Fikree also examines the emerging evidence for GLP-1 therapies in patients with IBS and chronic gastrointestinal symptoms, highlighting both the benefits and limitations of these increasingly prescribed treatments.
More episodes of BSG From Top to Bottom
More episodes
- Crohn’s Disease Fibrosis - Therapeutic Landscape
- How to be a Good Mentor
- Immunological and Therapeutic Frontiers in Coeliac Disease
- BSG From Top to Bottom - Trailer
- Introduction to the BSG with President, Prof. Colin Rees
- BSG Sedation Guidelines in Gastrointestinal Endoscopy
- Colorectal Polyps in Patients with Limited Life Expectancy
- BSG IBD Guideline - Methodology
- BSG IBD Guideline - De-escalation of Therapy
- BSG IBD Guideline - Acute Severe Ulcerative Colitis (ASUC)
PodSearch is a free, independent podcast search engine. Read about PodSearch, the privacy policy or contact us.